Rory Chan

1.2k total citations
71 papers, 564 citations indexed

About

Rory Chan is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Rory Chan has authored 71 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Physiology, 49 papers in Pulmonary and Respiratory Medicine and 22 papers in Immunology and Allergy. Recurrent topics in Rory Chan's work include Asthma and respiratory diseases (57 papers), Respiratory and Cough-Related Research (33 papers) and Allergic Rhinitis and Sensitization (22 papers). Rory Chan is often cited by papers focused on Asthma and respiratory diseases (57 papers), Respiratory and Cough-Related Research (33 papers) and Allergic Rhinitis and Sensitization (22 papers). Rory Chan collaborates with scholars based in United Kingdom, Italy and Singapore. Rory Chan's co-authors include Brian J. Lipworth, Chris RuiWen Kuo, Kirsten Stewart, Sunny Jabbal, Robert Greig, Francine M. Ducharme, Ai Ee Ling, W C Lye, Estela Monteiro and G Kumarasinghe and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Rory Chan

60 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rory Chan United Kingdom 14 445 335 135 65 61 71 564
Andrew Gillman Australia 8 230 0.5× 173 0.5× 52 0.4× 46 0.7× 12 0.2× 15 314
Dennis C. Jerome United States 4 191 0.4× 237 0.7× 100 0.7× 24 0.4× 30 0.5× 5 431
Christopher A. Coop United States 14 172 0.4× 43 0.1× 303 2.2× 27 0.4× 23 0.4× 39 466
Kugathasan Mutalithas United Kingdom 6 295 0.7× 279 0.8× 88 0.7× 59 0.9× 3 0.0× 9 426
Anju Tripathi United States 12 325 0.7× 92 0.3× 316 2.3× 42 0.6× 378 6.2× 18 687
Ajerico del Rosario United Kingdom 7 274 0.6× 137 0.4× 49 0.4× 242 3.7× 5 0.1× 10 435
Ann Decraene Belgium 8 145 0.3× 254 0.8× 13 0.1× 117 1.8× 9 0.1× 13 412
Ajmal Khan India 11 240 0.5× 412 1.2× 24 0.2× 16 0.2× 11 0.2× 37 526
D. Polzehl Germany 7 258 0.6× 75 0.2× 315 2.3× 21 0.3× 409 6.7× 9 549
Richard Loh Australia 5 58 0.1× 34 0.1× 144 1.1× 39 0.6× 46 0.8× 6 264

Countries citing papers authored by Rory Chan

Since Specialization
Citations

This map shows the geographic impact of Rory Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rory Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rory Chan more than expected).

Fields of papers citing papers by Rory Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rory Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rory Chan. The network helps show where Rory Chan may publish in the future.

Co-authorship network of co-authors of Rory Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Rory Chan. A scholar is included among the top collaborators of Rory Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rory Chan. Rory Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Rory, Els J.M. Weersink, René Lutter, et al.. (2025). Changes in Small Airway Physiology Measured by Impulse Oscillometry in Subjects with Allergic Asthma Following Methacholine and Inhaled Allergen Challenge. Journal of Clinical Medicine. 14(3). 906–906.
2.
Greig, Robert, Rory Chan, & Brian J. Lipworth. (2025). Oscillometry and spirometry derived ratios to assess small airways dysfunction in severe asthma patients taking tezepelumab. Respiratory Medicine. 241. 108072–108072. 2 indexed citations
3.
Greig, Robert, Rory Chan, & Brian J. Lipworth. (2025). Type 2 biomarkers and airway hyper-responsiveness disconnect in patients with uncontrolled severe asthma taking benralizumab or dupilumab. Annals of Allergy Asthma & Immunology. 135(4). 448–449. 1 indexed citations
4.
Greig, Robert, Rory Chan, Tom Fardon, & Brian J. Lipworth. (2025). Real-world effects of tezepelumab on small airway dysfunction in severe refractory asthma. Annals of Allergy Asthma & Immunology. 134(4). 484–485. 9 indexed citations
5.
Greig, Robert, Rory Chan, & Brian J. Lipworth. (2025). Worse airflow obstruction but not type 2 biomarkers identifies super-responders to tezepelumab in real life. Annals of Allergy Asthma & Immunology. 134(6). 732–734. 1 indexed citations
6.
Greig, Robert, Philipp Suter, Rory Chan, & Brian J. Lipworth. (2025). Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma. Respiratory Medicine. 247. 108315–108315. 2 indexed citations
7.
Suter, Philipp, Robert Greig, Rory Chan, & Brian J. Lipworth. (2025). Efficacy of dupilumab and mepolizumab in eosinophilic COPD: insights from phase 3 trials. Respiratory Medicine. 248. 108343–108343.
8.
Menzella, Francesco, et al.. (2025). An update on oscillometry in asthma. Expert Review of Respiratory Medicine. 19(11). 1097–1109.
9.
Suter, Philipp, Robert Greig, Chris RuiWen Kuo, Rory Chan, & Brian J. Lipworth. (2025). Comparison of oscillometry ratios between IOS and AOS in patients with asthma and COPD. Respiratory Medicine. 248. 108402–108402.
10.
Cottini, Marcello, Remo Poto, Atanu Bhattacharjee, et al.. (2025). Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma. Respiratory Medicine. 244. 108180–108180. 1 indexed citations
11.
Greig, Robert, Chris RuiWen Kuo, Rory Chan, & Brian J. Lipworth. (2024). Reversibility of airwave oscillometry in COPD. Respiratory Medicine. 236. 107915–107915. 1 indexed citations
12.
Greig, Robert, Kirsten Stewart, Rory Chan, & Brian J. Lipworth. (2024). Assessment of bronchodilator responsiveness using low-frequency impedance in type 2–high uncontrolled severe asthma. Annals of Allergy Asthma & Immunology. 134(2). 231–232. 1 indexed citations
13.
Ducharme, Francine M. & Rory Chan. (2024). Oscillometry in the diagnosis, assessment, and monitoring of asthma in children and adults. Annals of Allergy Asthma & Immunology. 134(2). 135–143. 8 indexed citations
14.
Chan, Rory & Brian J. Lipworth. (2023). The triple type 2 signature confers more frequent exacerbations and worse midexpiratory flow in moderate to severe asthma. The Journal of Allergy and Clinical Immunology In Practice. 11(9). 2926–2928.e1. 3 indexed citations
15.
Chan, Rory, et al.. (2023). Type 2 biomarkers and quality of life in chronic rhinosinusitis with nasal polyps. Annals of Allergy Asthma & Immunology. 131(6). 777–779. 2 indexed citations
16.
Lipworth, Brian J., Chris RuiWen Kuo, Kirsten Stewart, & Rory Chan. (2023). Should Airway Hyper-Responsiveness Be Included in the Definition of Clinical Remission With Biologic Therapy in Severe Asthma. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 904–907. 4 indexed citations
17.
Chan, Rory & Brian J. Lipworth. (2023). Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma. BMJ Open Respiratory Research. 10(1). e001472–e001472. 12 indexed citations
18.
19.
Chan, Rory & Brian J. Lipworth. (2023). Efficacy of biologic therapy on airway hyperresponsiveness in asthma. Annals of Allergy Asthma & Immunology. 131(1). 37–41. 12 indexed citations
20.
Hall, Rebecca, et al.. (2019). PRS59 QUALITATIVE ASSESSMENT OF THE CONTENT VALIDITY OF THE SNOT-22 IN PATIENTS WITH NASAL POLYPS. Value in Health. 22. S360–S360.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Gillman Breakdown of academic impact, for papers by Dennis C. Jerome Breakdown of academic impact, for papers by Christopher A. Coop Breakdown of academic impact, for papers by Kugathasan Mutalithas Breakdown of academic impact, for papers by Anju Tripathi Breakdown of academic impact, for papers by Ajerico del Rosario Breakdown of academic impact, for papers by Ann Decraene Breakdown of academic impact, for papers by Ajmal Khan Breakdown of academic impact, for papers by D. Polzehl Breakdown of academic impact, for papers by Richard Loh
Rankless by CCL
2026